Melatonin attenuates gray and white matter damage in a mouse model of transient focal cerebral ischemia

Journal of Pineal Research

Volumn 38, Issue 1, 2005, Pages 42-52

  Lee, E Jian ^a   Lee, Ming Yang ^a   Chen, Hung Yi ^b,c   Hsu, Yun Shang ^a   Wu, Tian Shung ^b   Chen, Shur Tzu ^b   Chang, Guan Liang ^a  

^a NATIONAL CHENG KUNG UNIVERSITY HOSPITAL   (Taiwan)

^b NATIONAL CHENG KUNG UNIVERSITY   (Taiwan)

^c CHINA MEDICAL UNIVERSITY   (Taiwan)

Author keywords

Focal cerebral ischemia; Gray matter; Melatonin; Oxidative stress; Stroke; White matter

Indexed keywords

4 HYDROXYNONENAL; 8 HYDROXYDEOXYGUANOSINE; AMYLOID PRECURSOR PROTEIN; MELATONIN; NEUROPROTECTIVE AGENT; TAU PROTEIN;

ANIMAL BEHAVIOR; ANIMAL MODEL; ANIMAL TISSUE; ARTICLE; BODY WEIGHT; BRAIN BLOOD FLOW; BRAIN ISCHEMIA; CONTROLLED STUDY; GRAY MATTER; LASER DOPPLER FLOWMETRY; LIPID PEROXIDATION; MIDDLE CEREBRAL ARTERY OCCLUSION; MOUSE; NEUROLOGIC EXAMINATION; NEUROPROTECTION; NONHUMAN; OLIGODENDROGLIA; OXIDATIVE STRESS; SCORING SYSTEM; STROKE; TREATMENT OUTCOME; WHITE MATTER;

ANIMALS; BRAIN; BRAIN ISCHEMIA; DNA; HYDROXYLATION; LIPID PEROXIDATION; MALE; MELATONIN; MICE; MICE, INBRED C57BL; OXIDATIVE STRESS;

EID: 12344318087     PISSN: 07423098     EISSN: None     Source Type: Journal    
DOI: 10.1111/j.1600-079X.2004.00173.x     Document Type: Article

References (47)

1. TRAYSTMAN RJ, KIRSCH JR, KOEHLER RC. Oxygen radical mechanisms of brain injury following ischemia and reperfusion. J Appl Physiol 1991; 71:1185-1195.
2. SIES H. Oxidative stress: oxidants and antoxidants. Exp Physiol 1997; 82:291-295.
3. CHAN PH. Reactive oxygen radicals in signaling and damage in the ischemic brain. J Cereb Blood Flow Metab 2001; 21:2-14.
4. MATTSON MP, DUAN W, PEDERSEN WA et al. Neurodegenerative disorders and ischemic brain diseases. Apoptosis 2001; 6:69-81.
5. IMAIZUMI S, KAYAMA T, SUZUKI J. Chemiluminescence in hypoxic brain - the first report. Correlation between energy metabolism and free radical reaction. Stroke 1984; 15:1061-1065.
6. SIESJÖ BK. Cerebral circulation and metabolism. J Neurosurg 1984; 60:883-908.
7. KURODA S, SIESJÖ BK. Reperfusion damage following focal ischemia: pathophysiology and therapeutic windows. Clin Neurosci 1997; 4:199-212.
8. CLEMENS JA. Cerebral ischemia: gene activation, neuronal injury, and the protective role of antioxidants. Free Radic Biol Med 2000; 28:1526-1531.
9. IMAI H, MCCULLOCH J, GRAHAM DI et al. New method for the quantitative assessment of axonal damage in focal cerebral ischemia. J Cereb Blood Flow Metab 2002; 22:1080-1089.
10. LEE EJ, WU TS, LEE MY et al. Delayed treatment with melatonin enhances electrophysiological recovery following transient focal cerebral ischemia in rats. J Pineal Res 2004; 36:33-42.
11. IMAI H, MASAYASU H, DEWAR D et al. Ebselen protects both gray and white matter in a rodent model of focal cerebral ischemia. Stroke 2001; 32:2149-2154.
12. SKAPER SD, FLOREANI M, CECCON M et al. Excitotoxicity, oxidative stress, and the neuroprotective potential of melatonin. Ann N Y Acad Sci 1999; 890:107-118.
13. CHEUNG RT. The utility of melatonin in reducing cerebral damage resulting from ischemia and reperfusion. J Pineal Res 2003; 34:153-160.
14. TAN DX, CHEN LD, POEGGELER B et al. Melatonin: a potent, endogenous hydroxyl radical scavenger. Endocr J 1993; 1:57-60.
15. REITER RJ, TAN DX, MANCHESTER LC et al. Biochemical reactivity of melatonin with reactive oxygen and nitrogen species: a review of the evidence. Cell Biochem Biophys 2001; 34:237-256.
16. TAN DX, REITER RJ, MANCHESTER LC et al. Chemical and physical properties and potential mechanisms: melatonin as a broad spectrum antioxidant and free radical scavenger. Curr Top Med Chem 2002; 2:181-197.
17. CUZZOCREA S, COSTANTINO G, GITTO E et al. Protective effects of melatonin in ischemic brain injury. J Pineal Res 2000; 29:217-227.
18. SINHA K, DEGAONKAR MN, JAGANNATHAN NR et al. Effect of melatonin on ischemia reperfusion injury induced by middle cerebral artery occlusion in rats. Eur J Pharmacol 2001; 428:185-192.
19. PEI Z, PANG SF, CHEUNG RT. Pretreatment with melatonin reduces volume of cerebral infarction in a rat middle cerebral artery occlusion stroke model. J Pineal Res 2002; 32:168-172.
20. EL-ABHAR HS, SHAALAN M, BARAKAT M et al. Effect of melatonin and nifedipine on some antioxidant enzymes and different energy fuels in the blood and brain of global ischemic rats. J Pineal Res 2002; 33:87-94.
21. HUSSON I, MESPLES B, BAC P et al. Melatoninergic neuroprotection of the murine periventricular white matter against neonatal excitotoxic challenge. Ann Neurol 2002; 51:82-92.
22. KAPTANOGLU E, PALAOGLU S, DEMIRPENCE E et al. Different responsiveness of central nervous system tissues to oxidative conditions and to the antioxidant effect of melatonin. J Pineal Res 2003; 34:32-35.
23. KILIC E, KILIC U, YULUG B et al. Melatonin reduces disseminate neuronal death after mild focal ischemia in mice via inhibition of caspase-3 and is suitable as an add-on treatment to tissue-plasminogen activator. J Pineal Res 2004; 36:171-176.
24. SCHOMER DF, MARKS MP, STEINBERG GK et al. The anatomy of the posterior communicating artery as a risk factor for ischemic cerebral infarction. N Engl J Med 1994; 330:1565-1570.
25. KITAGAWA K, MATSUMOTO M, YANG G et al. Cerebral ischemia after bilateral carotid artery occlusion and intraluminal suture occlusion in mice: evaluation of the patency of the posterior communicating artery. J Cereb Blood Flow Metab 1998; 18:570-579.
26. MCCOLL BW, CARSWELL HV, MCCULLOCH J et al. Extension of cerebral hypoperfusion and ischaemic pathology beyond MCA territory after intraluminal filament occlusion in C57B1/6J mice. Brain Res 2004; 997:15-23.
27. YELESWARAM K, MCLAUGHLIN LG, KNIPE JO et al. Pharmacokinetics and oral bioavailability of exogenous melatonin in preclinical animal models and clinical implications. J Pineal Res 1997; 22:45-51.
28. YIN XM, LUO Y, CAO G et al. Bid-mediated mitochondrial pathway is critical to ischemic neuronal apoptosis and focal cerebral ischemia. J Biol Chem 2002; 277:42074-42081.
29. MAO Y, YANG GY, ZHOU LF et al. Focal cerebral ischemia in the mouse: description of a model and effects of permanent and temporary occlusion. Mol Brain Res 1999; 63:366-370.
30. PIXINOS G, FRANKLIN KBJ. The Mouse Brain in Stereotaxic Coordinates. Academic Press, San Diego, CA, 2001.
31. KILIC E, BAHR M, HERMANN DM. Effects of recombinant tissue plasminogen activator after intraluminal thread occlusion in mice: role of hemodynamic alterations. Stroke 2001; 32:2641-2647.
32. CLARK WM, RINKER LG, LESSOV NS et al. Lack of interleukin-6 expression is not protective against focal central nervous system ischemia. Stroke 2000; 31:1715-1720.
33. MCCRACKEN E, DEWAR D, MCCULLOCH J. Sipatrigine and oligodendrocyte and axonal pathology following transient focal cerebral ischaemia in the rat. Neuroreport 2003; 14:517-520.
34. LEE EJ, CHEN HY, WU TS et al. Acute administration of Ginkgo biloba extract (EGb 761) affords neuroprotection against permanent and transient focal cerebral ischemia in Sprague-Dawley rats. J Neurosci Res 2002; 68:636-645.
35. VALERIANI V, DEWAR D, MCCULLOCH J. Quantitative assessment of ischemic pathology in axons, oligodendrocytes, and neurons: attenuation of damage after transient ischemia. J Cereb Blood Flow Metab 2000; 20:765-771.
36. IMAI H, GRAHAM DI, MASAYASU H et al. Antioxidant ebselen reduces oxidative damage in focal cerebral ischemia. Free Radic Biol Med 2003; 34:56-63.
37. SUN FY, LIN X, MAO LZ et al. Neuroprotection by melatonin against ischemic neuronal injury associated with modulation of DNA damage and repair in the rat following a transient cerebral ischemia. J Pineal Res 2002; 33:48-56.
38. PEI Z, FUNG PC, CHEUNG RT. Melatonin reduces nitric oxide level during ischemia but not blood-brain barrier breakdown during reperfusion in a rat middle cerebral artery occlusion stroke model. J Pineal Res 2003; 34:110-118.
39. REITER RJ, GUERRERO JM, GARCIA JJ et al. Reactive oxygen intermediates, molecular damage, and aging. Relation to melatonin. Ann N Y Acad Sci 1998; 854:410-424.
40. ACUÑA-CASTROVIEJO D, MARTIN M, MACIAS M et al. Melatonin, mitochondria, and cellular bioenergetics. J Pineal Res 2001; 30:65-74.
41. MARTIN M, MACIAS M, LEON J et al. Melatonin increases the activity of the oxidative phosphorylation enzymes and the production of ATP in rat brain and liver mitochondria. Int J Biochem Cell Biol 2002; 34:348-357.
42. LEON J, ACUNA-CASTROVIEJO D, SAINZ RM et al. Melatonin and mitochondrial function. Life Sci 2004; 75:765-790.
43. ANDRABI SA, SAYEED I, SIEMEN D et al. Direct inhibition of the mitochondrial permeability transition pore: a possible mechanism responsible for anti-apoptotic effects of melatonin. FASEB J 2004; 18:869-871.
44. KONDOH T, UNEYAMA H, NISHINO H et al. Melatonin reduces cerebral edema formation caused by transient forebrain ischemia in rats. Life Sci 2002; 72:583-590.
45. TORII K, UNEYAMA H, NISHINO H et al. Melatonin suppresses cerebral edema caused by middle cerebral artery occlusion/reperfusion in rats assessed by magnetic resonance imaging. J Pineal Res 2004; 36:18-24.
46. REGRIGNY O, DELAGRANGE P, SCALBERT E et al. Melatonin improves cerebral circulation security margin n rats. Am J Physiol 1998; 275:H139-H144.
47. MACGREGOR DG, CARSWELL HV, GRAHAM DI et al. Impaired cerebral autoregulation 24 h after induction of transient unilateral focal ischaemia in the rat. Eur J Neurosci 2000; 12:58-66.